Magnesium oxide and Epstein-barr virus associated lymphoproliferative disorder - a phase IV clinical study of FDA data

Summary:

Epstein-barr virus associated lymphoproliferative disorder is reported as a side effect among people who take Magnesium oxide (magnesium), especially for people who are male, 20-29 old, have been taking the drug for < 1 month also take Cyclophosphamide, and have Aplastic anemia.

The phase IV clinical study analyzes which people have Epstein-barr virus associated lymphoproliferative disorder when taking Magnesium oxide. It is created by eHealthMe based on reports of 18,625 people who have side effects when taking Magnesium oxide from the FDA, and is updated regularly.

What is Magnesium oxide?

Magnesium oxide has active ingredients of magnesium. It is often used in migraine. eHealthMe is studying from 19,022 Magnesium oxide users. Check the latest studies of Magnesium oxide.

What is Epstein-barr virus associated lymphoproliferative disorder?

Epstein-barr virus associated lymphoproliferative disorder (lymphocytes are produced in excessive quantities associated with epstein-barr virus) is found to be associated with 114 drugs and 359 conditions by eHealthMe. Check the latest studies of Epstein-barr virus associated lymphoproliferative disorder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 15, 2026

18,625 people reported to have side effects when taking Magnesium oxide.
Among them, 12 people (0.06%) have Epstein-barr virus associated lymphoproliferative disorder.

Could Magnesium oxide cause Epstein-barr virus associated lymphoproliferative disorder?

Among these 12 people:

How long have people been on Magnesium oxide when they have Epstein-barr virus associated lymphoproliferative disorder? *

What is the gender of people who have Epstein-barr virus associated lymphoproliferative disorder when taking Magnesium oxide? *

female: 27.27 %
male: 72.73 %

What is the age of people who have Epstein-barr virus associated lymphoproliferative disorder when taking Magnesium oxide? *

What are other drugs people take besides Magnesium oxide? *

Cyclophosphamide: 9 people, 75.00%
Methylprednisolone Sodium Succinate: 8 people, 66.67%
Fluconazole: 7 people, 58.33%
Hydrocortisone Sodium Succinate: 7 people, 58.33%
Methotrexate: 6 people, 50.00%
Cyclosporine: 6 people, 50.00%
Lansoprazole: 5 people, 41.67%
Tacrolimus: 5 people, 41.67%
Amlodipine Besylate: 5 people, 41.67%
Fludarabine Phosphate: 4 people, 33.33%

What are other side effects people have besides Epstein-barr virus associated lymphoproliferative disorder? *

Fever: 5 people, 41.67%
Thrombocytopenia (decrease of platelets in blood): 4 people, 33.33%
Liver Disorder (liver diseases): 4 people, 33.33%
Engraft Failure: 4 people, 33.33%
Febrile Neutropenia (fever with reduced white blood cells): 3 people, 25.00%
Gastric Ulcer Haemorrhage (bleeding ulcer of stomach): 2 people, 16.67%
Pseudomembranous Colitis (antibiotic-associated diarrhoea (aad), is an infection of the colon): 2 people, 16.67%
Herpes Zoster: 2 people, 16.67%
Enterococcal Infection: 2 people, 16.67%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 2 people, 16.67%

What are the existing conditions these people have? *

Aplastic Anemia: 8 people, 66.67%
Insomnia (sleeplessness): 7 people, 58.33%
Bone Marrow Conditioning Regimen: 5 people, 41.67%
Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 3 people, 25.00%
Proctitis (inflammation of the rectum and anus): 3 people, 25.00%
High Blood Pressure: 3 people, 25.00%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 3 people, 25.00%
Chronic Graft Versus Host Disease (immune cells attack the host's body cells after transplant): 3 people, 25.00%
Bone Marrow Disorder: 1 person, 8.33%
Carotid Artery Stenosis (narrowing of carotid artery): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Magnesium oxide and have Epstein-barr virus associated lymphoproliferative disorder?

- Check whether Epstein-barr virus associated lymphoproliferative disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Magnesium oxide:

Magnesium oxide (19,022 reports)

Epstein-barr virus associated lymphoproliferative disorder treatments and more:

Epstein-barr virus associated lymphoproliferative disorder (2,067 reports)

How severe was Epstein-barr virus associated lymphoproliferative disorder and when was it recovered:

Epstein-barr virus associated lymphoproliferative disorder in Magnesium oxide

Expand to all the drugs that have ingredients of magnesium:

Epstein-barr virus associated lymphoproliferative disorder and drugs with ingredients of magnesium (15 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Magnesium oxide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Epstein-barr virus associated lymphoproliferative disorder:

Epstein-barr virus associated lymphoproliferative disorder (114 drugs)

Browse all the conditions that are associated with Epstein-barr virus associated lymphoproliferative disorder:

Epstein-barr virus associated lymphoproliferative disorder (359 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on magnesium (the active ingredients of Magnesium oxide) and Magnesium oxide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.